These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 678343)

  • 21. [New therapeutic approaches to arterial hypertension].
    Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1982 Sep; 112(39):1330-4. PubMed ID: 6755692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin--angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients.
    Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Nielsen MD; Giese J
    Clin Sci Mol Med Suppl; 1978 Dec; 4():319s-321s. PubMed ID: 282078
    [No Abstract]   [Full Text] [Related]  

  • 23. Volume control and altered renal and adrenal responsiveness to angiotensin in essential hypertension: implications for treatment with converting enzyme inhibition.
    Hollenberg NK; Williams GH
    J Hypertens Suppl; 1983 Oct; 1(1):119-28. PubMed ID: 6100600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic and neurohumoral factors in the response of hypertensives to hydrochlorothiazide therapy.
    Fernandez PG; Snedden W; Nath C; Vasdev S; Lee C; Darke A
    Clin Invest Med; 1987 Nov; 10(6):513-9. PubMed ID: 3326694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension].
    Chazova IE; Mychka VB; Duishvili DE
    Ter Arkh; 2004; 76(8):28-32. PubMed ID: 15471392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.
    Wilkinson R; Sellars L; Pickering M; Robson V; Kerr DN
    Clin Nephrol; 1981 Dec; 16(6):307-13. PubMed ID: 7032775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of indomethacin alone and during diuretic or beta-adrenoreceptor-blockade therapy on blood pressure and the renin system in essential hypertension.
    Lopez-Ovejero JA; Weber MA; Drayer JI; Sealey JE; Laragh JH
    Clin Sci Mol Med Suppl; 1978 Dec; 4():203s-205s. PubMed ID: 282051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation between the hypotensive effect of thiazides and plasma divalent cations.
    Batlle DC; Yang WC; Von Riotte A; Mujais SK
    Adv Exp Med Biol; 1986; 208():433-41. PubMed ID: 3551542
    [No Abstract]   [Full Text] [Related]  

  • 31. [Essential hypertension with low plasmatic renin activity (PRA). Effects of propranolol on arterial pressure and reninemia].
    Santucci A; Aguglia F; Caputo V; De Mattia G; Cicconetti P; Balsano F
    Boll Soc Ital Cardiol; 1978; 23(8):1349-55. PubMed ID: 398713
    [No Abstract]   [Full Text] [Related]  

  • 32. Antihypertensive and renin angiotensin effects of metolazone with and without propranolol.
    Sambhi MP; Eggena P; Barrett JD; Thananopavarn C; Tuck M; Wiedman C
    J Clin Pharmacol; 1977 Apr; 17(4):214-24. PubMed ID: 849995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monotherapy in the treatment of hypertension.
    Morgan T
    Chest; 1983 Feb; 83(2 Suppl):419-22. PubMed ID: 6822142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin.
    Watkins J; Abbott EC; Hensby CN; Webster J; Dollery CT
    Br Med J; 1980 Sep; 281(6242):702-5. PubMed ID: 7427409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Exchange sodium and angiotensin II in the blood in essential arterial hypertension].
    Deutsch G; Cristodorescu R; Gavrilescu S; Berger E; Drugărin D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(2):113-9. PubMed ID: 17902
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of sodium intake in the antihypertensive effect of propranolol.
    Owens CJ; Brackett NC
    South Med J; 1978 Jan; 71(1):43-6. PubMed ID: 622601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary hypertension refractory to triple drug treatment: a study on central and peripheral hemodynamics.
    Andersson O; Hansson L; Sivertsson R
    Circulation; 1978 Oct; 58(4):615-22. PubMed ID: 688570
    [No Abstract]   [Full Text] [Related]  

  • 38. Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function.
    Millar EA; Angus RM; Hulks G; Morton JJ; Connell JM; Thomson NC
    Thorax; 1994 May; 49(5):492-5. PubMed ID: 8016772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical profile of essential arterial hypertension. Indications for a targeted therapy: experience with propranolol].
    Lauro R; Platania A; Liberatore C; Reda G; Spinelli C
    Clin Ter; 1978 Apr; 85(1):19-25. PubMed ID: 657741
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of bupranolol on the renin-angiotensin system in essential hypertension].
    Gavrilescu S; Deutsch G; Cristodorescu R; Comsulea L
    Med Welt; 1978 Mar; 29(11):439-41. PubMed ID: 651598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.